Compounds > pyridoxamine

pyridoxamine and glucuronyl glucosamine glycan sulfate

pyridoxamine has been researched along with glucuronyl glucosamine glycan sulfate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tuttle, KR; Williams, ME1
Williams, ME1
Angelini, ML; Baraldi, O; Cianciolo, G; Iorio, M; Stefoni, S1
Breyer, MD; Susztak, K1

Reviews

4 review(s) available for pyridoxamine and glucuronyl glucosamine glycan sulfate

ArticleYear
The next generation of diabetic nephropathy therapies: an update.
    Advances in chronic kidney disease, 2005, Volume: 12, Issue:2

    Topics: Animals; Diabetic Nephropathies; Disease Progression; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Indoles; Maleimides; Models, Animal; Protein Kinase C; Pyridoxamine; Renal Agents; Thiazoles

2005
New potential agents in treating diabetic kidney disease: the fourth act.
    Drugs, 2006, Volume: 66, Issue:18

    Topics: Animals; Diabetic Nephropathies; Drugs, Investigational; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Indoles; Maleimides; Protein Kinase C; Protein Kinase Inhibitors; Pyridoxamine; Renal Agents; Treatment Outcome

2006
Emerging drugs for chronic kidney disease.
    Expert opinion on emerging drugs, 2014, Volume: 19, Issue:2

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Glycosaminoglycans; Humans; Pyridines; Pyridoxamine; Pyrimidines; Pyrrolidines; Renal Insufficiency, Chronic

2014
Developing Treatments for Chronic Kidney Disease in the 21st Century.
    Seminars in nephrology, 2016, Volume: 36, Issue:6

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Atrasentan; Benzhydryl Compounds; Canagliflozin; Diabetic Nephropathies; Drug Discovery; Endothelin Receptor Antagonists; Glucosides; Glycosaminoglycans; Humans; Hypoglycemic Agents; Mineralocorticoid Receptor Antagonists; Oleanolic Acid; Oxidative Stress; Pyridoxamine; Pyrrolidines; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors

2016